ACL vs NXN

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

51MEDIUM

NXN

NEXSEN LTD FPO [NXN]

51MEDIUM

Score Breakdown

ACL NXN
Technical
51
62
Catalyst
71
50
Sentiment
50
50
Fundamental
68
66
Momentum
52
54
Risk Gate
36
42

Key Metrics

ACL Metric NXN
$433.7MMarket Cap$59.1M
575KAvg Volume (20d)166K
+6.5%Short InterestN/A
$2.97052-Week High$0.345
$1.83352-Week Low$0.130
+0.0%Daily Change+3.5%
$2.330Reference Price$0.295
+16.7%ROEN/A
+3.6%Profit MarginN/A

Active Signals

ACL Signals

Trading above both moving averages — the trend is your friend here
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
New substantial holder(s) (1)

NXN Signals

Trading above both moving averages — the trend is your friend here
Watch out — volume is flowing out even as price holds up. Distribution pattern
Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Adequate cash runway (8 quarters)
Very high P/S ratio (63.4x)
Piotroski F-Score weak (3/9, low-confidence approx)
Small-cap ($20-100M)
CANSLIM S: Tight float (32%)

Ask Scout AI to compare ACL and NXN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NTI vs NUZ →NTI vs SLD →NTI vs TRJ →NUZ vs SLD →NUZ vs TRJ →
ACL Full Analysis → NXN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).